Clinical Trial Update: Post-market Clinical Trial of the Dominus® Stent-Graft

View source ↗

Summary

A post-market clinical trial evaluating the Dominus Stent-Graft by Braile Biomedica is currently recruiting patients with thoracic aortic dissection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Aortic Dissection

Drugs mentioned

• Dominus Stent-Graft

Snippet

Sponsor: Braile Biomedica Ind. Com. e Repr. Ltda. | Conditions: Thoracic Aortic Dissection | Status: RECRUITING